Coronary angioplasty for unstable angina
Related Experiment Videos
1Catheterization Laboratory, University Hospital Dijkzigt, Erasmus University Rotterdam, The Netherlands.
Insights
Coronary angioplasty effectively treats unstable angina but carries risks of acute closure. Newer antiplatelet or antithrombin agents may improve safety for this procedure.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Unstable angina requires effective treatment strategies.
- Coronary angioplasty offers high initial success but poses risks of acute closure due to plaque injury and thrombus formation.
Framework:
- Coronary angioplasty is indicated when a suitable stenosis causes unstable angina.
- Treatment decisions vary based on coronary artery disease complexity (single-vessel vs. multivessel).
Implementation:
- Percutaneous coronary intervention (PCI) is favored for single-vessel disease.
- Bypass surgery is primary for left main stem or severe multivessel disease.
- Culprit vessel-only PCI may be preferred in selected multivessel disease cases for faster procedures and shorter hospital stays.
Implications:
- Novel antiplatelet and antithrombin agents may enhance the safety of coronary angioplasty in unstable angina.
- Thrombolytic therapy is considered for patients with intracoronary thrombi or procedural acute closure.
Abstract:
Coronary angioplasty is an effective treatment for subgroups of patients with unstable angina. The procedure has a high initial success rate but there is an increased risk of major complications resulting from a higher incidence of acute closure presumably related to additional injury of the underlying plaque with augmented platelet and clotting activity, and ensuing spasm. Newer agents that inhibit platelet aggregation or thrombin may provide a safer use of coronary angioplasty in patients with unstable angina. Coronary angioplasty is indicated if a stenosis, technically suitable for dilation, is found to be responsible for the unstable state. The decision in favor of coronary angioplasty in patients with single-vessel disease is easy to make. Patients with left main stem disease or severe multivessel disease should primarily be scheduled for bypass surgery. In the presence of other multivessel disease, uncertainty remains. However, in selected patients with multivessel disease, one might prefer dilation of the ischemia-related vessel "the culprit vessel" only, rather than total revascularization by multiple dilatations or bypass surgery, since this can be performed faster and thus shorten the hospital stay. Thrombolytic treatment in the management of patients with unstable angina may be indicated in patients with pre-existing intracoronary thrombi or when procedural acute closure occurs associated with intracoronary thrombus formation.